Market Overview:
The global thiabendazole market is expected to grow at a CAGR of 3.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for thiabendazole as a preservative and an antifungal agent, and increasing awareness about its benefits among consumers. Additionally, the growing demand for thiabendazole in emerging economies is also contributing to the growth of the market. However, stringent regulatory norms regarding its use are restraining the growth of this market. On the basis of type, powder accounted for a larger share of the global thiabendazole market in 2017. This can be attributed to its easy availability and low cost as compared to other forms such as liquid form. On account of its high efficacy against various types of parasites, it is increasingly being used by livestock farmers across regions worldwide.
Product Definition:
Thiabendazole is a benzimidazole anti-helminthic agent that is used to treat infections caused by nematodes and trematodes. It functions by inhibiting the production of microtubules in the parasites, which leads to their death.
Powder:
Powder is a fine, white or nearly white solid material. It's appearance is very similar to granular substance and has a slightly sweet odor. Powder can be easily dissolved in water or alcohol and has no taste on itself.
Liquid:
Liquid is a solution of thiabendazole in water. It is used for the treatment of head lice, scabies and other parasitic infections. Liquid is applied to the skin with a cotton swab or by hand directly into the affected area. The concentration of thiabendazole in liquid depends on its strength as per its usage but generally contains around 95% w/w to 99% w/w.
Application Insights:
The preservative application segment dominated the global market in terms of revenue share in 2017. The demand for thiabendazole as a preservative is expected to grow owing to its broad spectrum preservation properties that prevent the growth of bacteria, fungi and other parasites. It also acts as an inhibitor for microorganisms which includes bacteria, molds, and fungus.
The antiparasitic agent segment is projected to witness lucrative growth over the forecast period due to increasing product usage against various types of parasitic diseases including loiasis (a disease caused by Loa loa), filaria (elephantiasis), and onchocerciasis (river blindness). In addition, it has been found effective against trypanosomiasis which is commonly known as sleeping sickness or nagana cure. Increasing awareness about these diseases coupled with rising healthcare spending are anticipated to drive product demand over the forecast period.
Regional Analysis:
North America was the largest regional market in 2017 and is anticipated to witness a significant growth rate of 4.8% over the forecast period. The region has been witnessing increasing demand for thiabendazole from major application sectors, such as agriculture, feed & food additives, veterinary medicine and human health. Increasing consumption of meat products is one of the key factors driving product demand in this region. According to data published by Global Meat Trends (GMT), U.S.
Asia Pacific emerged as the fastest-growing regional market for thiabendazole with a CAGR exceeding 5% during the forecast period owing to rapid industrialization coupled with rising awareness about hygiene standards in emerging economies including India, China.
Growth Factors:
- Increasing prevalence of parasitic infections: The increasing prevalence of parasitic infections is one of the major growth drivers for the thiabendazole market. According to a study by the World Health Organization (WHO), approximately 2 billion people are infected with parasites, and more than 1 million people die from these infections every year. This number is expected to increase in the coming years due to the growing population and changing lifestyles.
- Rising awareness about parasitic diseases: There is a growing awareness among people about parasitic diseases and their symptoms, which is driving them to seek treatment options such as thiabendazole. This has led to an increase in demand for this drug worldwide.
- Growing demand for generic drugs: The high cost of branded drugs has led many patients around the world to switch over to cheaper generic versions available in the market today. Thiabendazole is available as a generic drug, which makes it affordable for most patients, thereby boosting its demand globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Thiabendazole Market Research Report
By Type
Powder, Liquid
By Application
Preservative, Antifungal Agent, Antiparasitic Agent, Other
By Companies
Kenvos Biotech, Merial U.S., Jiangsu Noon Crop Science, CTS Group, AKITA KONNO CO., LTD, Shanghai Skyblue Chemical Co., Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
152
Number of Tables & Figures
107
Customization Available
Yes, the report can be customized as per your need.
Global Thiabendazole Market Report Segments:
The global Thiabendazole market is segmented on the basis of:
Types
Powder, Liquid
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Preservative, Antifungal Agent, Antiparasitic Agent, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Kenvos Biotech
- Merial U.S.
- Jiangsu Noon Crop Science
- CTS Group
- AKITA KONNO CO., LTD
- Shanghai Skyblue Chemical Co., Ltd.
Highlights of The Thiabendazole Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Powder
- Liquid
- By Application:
- Preservative
- Antifungal Agent
- Antiparasitic Agent
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Thiabendazole Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Thiabendazole is a medication used to treat fungal infections. It works by killing the fungus.
Some of the major companies in the thiabendazole market are Kenvos Biotech, Merial U.S., Jiangsu Noon Crop Science, CTS Group, AKITA KONNO CO., LTD, Shanghai Skyblue Chemical Co., Ltd..
The thiabendazole market is expected to grow at a compound annual growth rate of 3.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Thiabendazole Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Thiabendazole Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Thiabendazole Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Thiabendazole Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Thiabendazole Market Size & Forecast, 2018-2028
4.5.1 Thiabendazole Market Size and Y-o-Y Growth
4.5.2 Thiabendazole Market Absolute $ Opportunity
Chapter 5 Global Thiabendazole Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Thiabendazole Market Size Forecast by Type
5.2.1 Powder
5.2.2 Liquid
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Thiabendazole Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Thiabendazole Market Size Forecast by Applications
6.2.1 Preservative
6.2.2 Antifungal Agent
6.2.3 Antiparasitic Agent
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Thiabendazole Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Thiabendazole Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Thiabendazole Analysis and Forecast
9.1 Introduction
9.2 North America Thiabendazole Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Thiabendazole Market Size Forecast by Type
9.6.1 Powder
9.6.2 Liquid
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Thiabendazole Market Size Forecast by Applications
9.10.1 Preservative
9.10.2 Antifungal Agent
9.10.3 Antiparasitic Agent
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Thiabendazole Analysis and Forecast
10.1 Introduction
10.2 Europe Thiabendazole Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Thiabendazole Market Size Forecast by Type
10.6.1 Powder
10.6.2 Liquid
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Thiabendazole Market Size Forecast by Applications
10.10.1 Preservative
10.10.2 Antifungal Agent
10.10.3 Antiparasitic Agent
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Thiabendazole Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Thiabendazole Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Thiabendazole Market Size Forecast by Type
11.6.1 Powder
11.6.2 Liquid
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Thiabendazole Market Size Forecast by Applications
11.10.1 Preservative
11.10.2 Antifungal Agent
11.10.3 Antiparasitic Agent
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Thiabendazole Analysis and Forecast
12.1 Introduction
12.2 Latin America Thiabendazole Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Thiabendazole Market Size Forecast by Type
12.6.1 Powder
12.6.2 Liquid
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Thiabendazole Market Size Forecast by Applications
12.10.1 Preservative
12.10.2 Antifungal Agent
12.10.3 Antiparasitic Agent
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Thiabendazole Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Thiabendazole Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Thiabendazole Market Size Forecast by Type
13.6.1 Powder
13.6.2 Liquid
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Thiabendazole Market Size Forecast by Applications
13.10.1 Preservative
13.10.2 Antifungal Agent
13.10.3 Antiparasitic Agent
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Thiabendazole Market: Competitive Dashboard
14.2 Global Thiabendazole Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Kenvos Biotech
14.3.2 Merial U.S.
14.3.3 Jiangsu Noon Crop Science
14.3.4 CTS Group
14.3.5 AKITA KONNO CO., LTD
14.3.6 Shanghai Skyblue Chemical Co., Ltd.
